Expression profiles associated with aggressive behavior in Merkel cell carcinoma

scientific article published on 17 November 2006

Expression profiles associated with aggressive behavior in Merkel cell carcinoma is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1040566359
P356DOI10.1038/MODPATHOL.3800717
P698PubMed publication ID17115023

P50authorLuis PuigQ42669207
P2093author name stringCarlos Ferrándiz
Aurelio Ariza
Eva Musulén
Enrique Lerma
Sergio Serrano
Montserrat Gilaberte
María-Teresa Fernández-Figueras
P2860cites workLinks between alpha-catenin, NF-kappaB, and squamous cell carcinoma in skinQ24541453
Tissue inhibitors of metalloproteinases: evolution, structure and functionQ28138083
Merkel cell carcinoma: prognosis and treatment of patients from a single institutionQ28242597
CpG island methylation and expression of tumour-associated genes in lung carcinomaQ30320221
Merkel-cell carcinoma of the skinQ35909583
Matrix metalloproteinases as therapeutic targets in cancerQ36126571
Merkel cells, normal and neoplastic: an updateQ36203819
Survivin, a cancer target with an emerging role in normal adult tissuesQ36491426
PPAR-gamma is expressed and NF-kB pathway is activated and correlates positively with COX-2 expression in stromal myofibroblasts surrounding colon adenocarcinomasQ38440573
p38 regulates cyclooxygenase-2 in human mammary epithelial cells and is activated in premalignant tissueQ38443641
Tissue micro-array: a cost and time-effective method for correlative studies by regional and national cancer study groupsQ38454152
Absence of classical MAP kinase pathway signalling in Merkel cell carcinomaQ40312042
Essential role of p38gamma in K-Ras transformation independent of phosphorylationQ40430785
Nuclear survivin is a powerful novel prognostic marker in gastroenteropancreatic neuroendocrine tumor diseaseQ40432966
Mitogen-activated protein kinase phosphatase-1 is overexpressed in non-small cell lung cancer and is an independent predictor of outcome in patients.Q40550067
Gene-expression profiling reveals distinct expression patterns for Classic versus Variant Merkel cell phenotypes and new classifier genes to distinguish Merkel cell from small-cell lung carcinomaQ40593745
Expression and prognostic significance of matrix metalloproteinases and their tissue inhibitors in primary neuroendocrine carcinoma of the skinQ40603566
Expression of bcl-6 protein in normal skin and epidermal neoplasmsQ41089601
Nuclear factor-kappaB dimer exchange promotes a p21(waf1/cip1) superinduction response in human T leukemic cellsQ42491580
Twenty-year follow-up study of long-term survival of limited-stage small-cell lung cancer and overview of prognostic and treatment factorsQ43418874
UV-B-type mutations and chromosomal imbalances indicate common pathways for the development of Merkel and skin squamous cell carcinomasQ43981132
Merkel cell carcinoma: analysis of clinical, histologic, and immunohistologic features of 132 cases with relation to survivalQ44244548
c-kit expression in primary and metastatic merkel cell carcinomaQ45201428
The 9 lives of beta-cateninQ47369148
PTEN/MMAC1 mutations identified in small cell, but not in non-small cell lung cancersQ47720095
Validation of tissue microarray technology in ovarian carcinomaQ47791732
Frequent allelic loss at 10q23 but low incidence of PTEN mutations in Merkel cell carcinoma.Q49065989
Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I nonsmall cell lung carcinoma.Q51674929
Neuroendocrine differentiation in extrahepatic bile duct carcinomas and its prognostic significance.Q53355566
Cyclooxygenase-2 expression in primary Merkel cell carcinoma.Q53361545
Immunohistochemical differential diagnosis between large cell neuroendocrine carcinoma and small cell carcinoma by tissue microarray analysis with a large antibody panel.Q53622297
Optimization of antibodies for detection of the mismatch repair proteins MLH1, MSH2, MSH6, and PMS2 using a biotin-free visualization system.Q54613560
A subset of high-grade pulmonary neuroendocrine carcinomas shows up-regulation of matrix metalloproteinase-7 associated with nuclear β-catenin immunoreactivity, independent of EGFR and HER-2 gene amplification or expressionQ56779554
Expression and Prognostic Significance of Metalloproteinases and Their Tissue Inhibitors in Patients With Small-Cell Lung CancerQ57272687
Expression of bcl-2 and p53 in Merkel cell carcinoma. An immunohistochemical studyQ71531368
CD44 expression in Merkel cell carcinoma may correlate with risk of metastasisQ71624279
CD56: a useful marker for diagnosing Merkel cell carcinomaQ73342835
Expression of matrix metalloproteinase-26 and tissue inhibitors of metalloproteinases TIMP-3 and -4 in benign endometrium and endometrial cancerQ73507201
Expression of adhesion molecules and cytokeratin 20 in merkel cell carcinomasQ80425901
The prognostic influence of neuroendocrine differentiation in breast cancer: results of a long-term follow-up studyQ80484346
TIMP-3 deficiency in the host, but not in the tumor, enhances tumor growth and angiogenesisQ81267255
Neuroendocrine differentiation in non-small cell lung cancer and its relation to prognosis and therapyQ81366824
Overexpression of hypoxia-inducible factor HIF-1alpha predicts early relapse in breast cancer: retrospective study in a series of 745 patientsQ81682235
Prognostic significance of p27Kip1, p45Skp2 and Ki67 expression profiles in Merkel cell carcinoma, extracutaneous small cell carcinoma, and cutaneous squamous cell carcinomaQ81775303
Clinicopathological and immunohistochemical analysis of 20 cases of Merkel cell carcinoma in search of prognostic markersQ81775306
The functional polymorphism in the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinomaQ81805558
Abnormal beta-catenin and reduced axin expression are associated with poor differentiation and progression in non-small cell lung cancerQ83180916
Epidemiology of primary Merkel cell carcinoma in the United StatesQ94325468
P433issue1
P921main subjectMerkel cell carcinomaQ1711744
P304page(s)90-101
P577publication date2006-11-17
P1433published inModern PathologyQ15724578
P1476titleExpression profiles associated with aggressive behavior in Merkel cell carcinoma
P478volume20

Reverse relations

cites work (P2860)
Q34274250A Proteomic Study of Human Merkel Cell Carcinoma
Q37550569Activation of PI3K signaling in Merkel cell carcinoma
Q34170708Activation of the PI3K/AKT pathway in Merkel cell carcinoma
Q36892143An unusual case of Merkel cell carcinoma
Q48002445Clinical Implications of CD8+ T-cell infiltration in frequent and rare cancers
Q35909855Detection of mitotic figures and G2+ tumor nuclei with histone markers correlates with worse overall survival in patients with Merkel cell carcinoma
Q36684979Distinct gene expression profiles of viral- and nonviral-associated merkel cell carcinoma revealed by transcriptome analysis
Q83553156Evidence for distinct populations of human Merkel cells
Q39773470Expression of MMP-10, MMP-21, MMP-26, and MMP-28 in Merkel cell carcinoma
Q64949324Histogenesis of Merkel Cell Carcinoma: A Comprehensive Review.
Q34985137Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors.
Q27001095Hypoxia-inducible factor 1 and its role in viral carcinogenesis
Q34688574Increased expression of matrix metalloproteinases-21 and -26 and TIMP-4 in pancreatic adenocarcinoma
Q38114084Merkel cell carcinoma of left groin: a case report and literature review.
Q26796421Merkel cell carcinoma of the head and neck: pathogenesis, current and emerging treatment options
Q38682926Merkel cell carcinoma: Do you know your guidelines?
Q43239986Merkel cell carcinoma: chemotherapy and emerging new therapeutic options
Q27021034Mutational analysis of merkel cell carcinoma
Q46847155Silent mutations in KIT and PDGFRA and coexpression of receptors with SCF and PDGFA in Merkel cell carcinoma: implications for tyrosine kinase-based tumorigenesis
Q41458291Systemic Therapy for Merkel Cell Carcinoma: What's on the Horizon?
Q48239064Tumor vascularization and clinicopathologic parameters as prognostic factors in merkel cell carcinoma.
Q41839134Vulvar merkel carcinoma: a case report
Q85335650[Merkel cell carcinoma]

Search more.